Press Releases

All Releases
View Summary Five Prime Therapeutics, Inc. Announces Milestone for TherapeuticProgram
Wednesday, February 24, 2010
PDF 6.5 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Wednesday, November 11, 2009
PDF 5.9 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. Adds Key Leaders to Its Management Team
Thursday, October 15, 2009
PDF 6.8 KB Add to Briefcase
View Summary FivePrime Appoints Julia Gregory Chief Executive Officer and Member of Board of Directors
Tuesday, June 9, 2009
PDF 6.6 KB Add to Briefcase
View Summary FivePrime Initiates Phase 1 Clinical Trials of FP-1039 in Patients with Advanced Cancers
Monday, September 8, 2008
PDF 7.1 KB Add to Briefcase
View Summary FivePrime and Pfizer enter Oncology and Diabetes Collaboration
Tuesday, May 20, 2008
PDF 6.5 KB Add to Briefcase
View Summary FivePrime Reports Discovery of IL-34
Thursday, May 8, 2008
PDF 97.8 KB Add to Briefcase
View Summary FivePrime achieves target discovery milestone with Boehringer Ingelheim
Monday, October 1, 2007
PDF 5.2 KB Add to Briefcase
View Summary FivePrime enters Osteoarthritis and Pulmonary Fibrosis Collaboration with Centocor
Wednesday, January 3, 2007
PDF 6.1 KB Add to Briefcase
View Summary Mark McDade to join FivePrime Board of Directors
Monday, August 7, 2006
PDF 6.6 KB Add to Briefcase
View Summary FivePrime and Boehringer Ingelhein Initiate Rheumatoid Arthritis Collaboration
Tuesday, April 25, 2006
PDF 7.7 KB Add to Briefcase
View Summary Biosite and FivePrime Announce Antibody Collaboration
Tuesday, February 21, 2006
PDF 8.4 KB Add to Briefcase
Showing 181-192 of 192 Page: 1 ... 6 7 8 9 10  Previous 20
Add to Briefcase = add release to Briefcase

FPRX (Common Stock)

Exchange
NASDAQ
Price
20.05
Change (%)
0.00
Volume
N/A

Data as of 4:00 PM ET on Friday, December 15, 2017
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.